Compass Therapeutics developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies.

Register for Details

For more details on financing and valuation for Compass Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Compass Therapeutics's ticker symbol?


What is Compass Therapeutics's stock price?

1.96 as of 9/22/23

Learn more about Compass Therapeutics

Forge green plus iconForge green minus icon

When was Compass Therapeutics founded?

Compass Therapeutics was founded in 2018.
Updated on: Jun 12, 2022